Tag: joint

GOTHENBURG, Sweden, June 25, 2026 /PRNewswire/ -- As the year's most important tournament approaches, SKF is launching a new collection of match kits designed by...

Collaboration allows entrepreneurs to reward key employees and create a plan for succession without giving up ownershipLAS VEGAS, June 25, 2026 /PRNewswire/ -- Reins,...

Exhale Wellness 2026 survey: 70% of THCA pre-roll buyers cite convenience as shoppers move from loose flower to lab-tested, ready-to-smoke hemp pre-rolls.

ORLANDO, Fla., June 25, 2026 /PRNewswire/ -- Commissioned in April 2026, the new Water Treatment Plant in Chatham, MA helps the Town meet Massachusetts...

Native video, custom audience targeting, and real-time optimization helped GUESS FRAGRANCES beat engagement benchmarks during one of advertising's most competitive momentsCANNES, France, June 25,...

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 24, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) announces...

Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 24, 2026 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) announces...

Key Highlights:SeAH Besteel Holdings is actively targeting the global aerospace materials market by leveraging SeAH Group's accumulated expertise in special alloy technologies, global OEM...

HONG KONG, June 25, 2026 /PRNewswire/ -- Joyson Electronics (0699.HK / 600699.SH), a leading global provider of smart technology solutions, announced the official opening...

We have so many choices – let's choose the best one Assuming it's the same group Neugebauer told market they were contracting on the earnings...

From the Studio to Center Court, the Young Investor Backs a Brand Built for the Next Generation of Athletes.BOCA RATON, Fla., June 24, 2026...